Key Segments:
By Component
-
Hardware
-
Software
-
Services
By Process
-
Upstream Processing
-
Downstream Processing
-
Fill-Finish
-
Quality Control
-
Other Processes
By Application
-
Research
-
Clinical
-
Commercial
By Cell Type
-
T-Cells
-
Stem Cells
-
Natural Killer (NK) Cells
-
Other Cell Types
By End-User
-
Pharmaceutical & Biotechnology Companies
-
Research Institutes
-
Contract Manufacturing Organizations (CMOs)
-
Other End-Users
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The Cell Therapy Manufacturing Automation Market is expected to grow at a CAGR of 14.55% from 2026 to 2035.
The Cell Therapy Manufacturing Automation Market was valued at USD 3.34 billion in 2025.
The major growth factor is growing demand for gene and cell therapies, driving adoption of automation to achieve scalable, standardized, cost-effective, and high-quality manufacturing while reducing contamination and manual errors.
The Hardware segment dominated the Cell Therapy Manufacturing Automation Market in 2025.
North America dominated the Cell Therapy Manufacturing Automation Market in 2025.